The Cooper Cos. (NYSE:COO) – Analysts at Northcoast Research reduced their Q1 2017 earnings estimates for shares of The Cooper Cos. in a research report issued to clients and investors on Monday. Northcoast Research analyst D. Keiser now anticipates that the brokerage will post earnings of $2.11 per share for the quarter, down from their previous estimate of $2.12.

The Cooper Cos. (NYSE:COO) last posted its quarterly earnings results on Thursday, September 1st. The medical device company reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.29 by $0.01. The Cooper Cos. had a return on equity of 14.89% and a net margin of 13.14%. The business earned $514.70 million during the quarter. During the same quarter in the previous year, the business posted $1.97 EPS. The company’s revenue for the quarter was up 11.5% on a year-over-year basis. WARNING: This piece of content was originally reported by Financial Market News and is the propert of of Financial Market News. If you are viewing this piece of content on another site, it was illegally stolen and republished in violation of US and international trademark and copyright legislation. The original version of this piece of content can be accessed at http://www.financial-market-news.com/northcoast-research-brokers-cut-earnings-estimates-for-the-cooper-cos-coo/1212220/.

Earnings History and Estimates for The Cooper Cos. (NYSE:COO)

A number of other brokerages have also recently commented on COO. Stifel Nicolaus reaffirmed a “buy” rating and set a $215.00 price target on shares of The Cooper Cos. in a research report on Friday, September 9th. Jefferies Group upped their price objective on shares of The Cooper Cos. from $190.00 to $210.00 and gave the company a “buy” rating in a report on Wednesday, August 24th. BMO Capital Markets upped their price objective on shares of The Cooper Cos. from $199.00 to $206.00 and gave the company an “outperform” rating in a report on Friday, September 2nd. Wells Fargo & Co. reiterated a “hold” rating on shares of The Cooper Cos. in a report on Sunday, September 11th. Finally, Zacks Investment Research lowered shares of The Cooper Cos. from a “buy” rating to a “hold” rating in a report on Friday, August 5th. Four analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $187.80.

The Cooper Cos. (NYSE:COO) opened at 164.49 on Tuesday. The company has a market cap of $8.02 billion, a PE ratio of 32.21 and a beta of 0.62. The company’s 50-day moving average price is $175.49 and its 200-day moving average price is $175.95. The Cooper Cos. has a 12-month low of $119.28 and a 12-month high of $190.99.

A number of large investors have recently bought and sold shares of the stock. Private Trust Co. NA raised its stake in The Cooper Cos. by 1.1% in the second quarter. Private Trust Co. NA now owns 2,898 shares of the medical device company’s stock valued at $497,000 after buying an additional 32 shares during the period. Mn Services Vermogensbeheer B.V. raised its stake in The Cooper Cos. by 3.0% in the third quarter. Mn Services Vermogensbeheer B.V. now owns 1,240 shares of the medical device company’s stock valued at $222,000 after buying an additional 36 shares during the period. Calvert Investment Management Inc. raised its stake in The Cooper Cos. by 1.4% in the second quarter. Calvert Investment Management Inc. now owns 2,945 shares of the medical device company’s stock valued at $505,000 after buying an additional 41 shares during the period. Sumitomo Mitsui Asset Management Company LTD raised its stake in The Cooper Cos. by 1.5% in the second quarter. Sumitomo Mitsui Asset Management Company LTD now owns 3,331 shares of the medical device company’s stock valued at $571,000 after buying an additional 49 shares during the period. Finally, Profit Investment Management LLC raised its stake in The Cooper Cos. by 1.5% in the second quarter. Profit Investment Management LLC now owns 3,291 shares of the medical device company’s stock valued at $565,000 after buying an additional 50 shares during the period. Hedge funds and other institutional investors own 98.06% of the company’s stock.

WARNING: This piece of content was originally reported by Financial Market News and is the propert of of Financial Market News. If you are viewing this piece of content on another site, it was illegally stolen and republished in violation of US and international trademark and copyright legislation. The original version of this piece of content can be accessed at http://www.financial-market-news.com/northcoast-research-brokers-cut-earnings-estimates-for-the-cooper-cos-coo/1212220/.

In other news, Director William A. Kozy acquired 270 shares of the firm’s stock in a transaction on Tuesday, September 6th. The stock was purchased at an average price of $186.69 per share, for a total transaction of $50,406.30. Following the purchase, the director now owns 770 shares in the company, valued at approximately $143,751.30. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Albert G. White III sold 20,000 shares of the stock in a transaction dated Wednesday, September 14th. The shares were sold at an average price of $185.72, for a total transaction of $3,714,400.00. Following the completion of the sale, the executive vice president now owns 41,639 shares of the company’s stock, valued at approximately $7,733,195.08. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

About The Cooper Cos.

The Cooper Companies, Inc (Cooper) is a medical device company. The Company operates through two business units: CooperVision, Inc (CooperVision) and CooperSurgical, Inc (CooperSurgical). CooperVision develops, manufactures and markets a range of soft contact lenses for the vision correction market. CooperVision offers Biofinity monthly spherical, toric and multifocal lenses under the Avaira brand.

5 Day Chart for NYSE:COO

Receive News & Ratings for The Cooper Cos. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cooper Cos. and related companies with MarketBeat.com's FREE daily email newsletter.